Aficamten improves oxygen uptake in patients with obstructive hypertrophic cardiomyopathy
1. In this randomized controlled trial, aficamten significantly improved peak oxygen uptake in...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 147 results for 'Hypertrophic Cardiomyopathy'
#VisualAbstract: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine,...
Read More
Aficamten Significantly Improves Peak Oxygen Uptake in Obstructive Hypertrophic Cardiomyopathy
Treatment with the oral selective cardiac myosin inhibitor aficamten results in significantly...
Read More
Guidelines Developed for Management of Hypertrophic Cardiomyopathy
THURSDAY, May 9, 2024 (HealthDay News) — In a new clinical guideline issued by the American...
Read MoreProlonged mHealth-Based Arrhythmia Monitoring in Patients With Hypertrophic Cardiomyopathy (HCM-PATCH): Protocol for a Single-Center Cohort Study.
Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of sudden cardiac death (SCD) due to ventricular arrhythmias and other arrhythmias. Screening for arrhythmias is mandatory to assess the individual SCD risk,...
Read More
Effects of Exercise Training in Hypertrophic Cardiomyopathy Patients
The following is a summary of “Randomized Controlled Trial of Moderate‐ and High‐Intensity...
Read More
Clinical benefits of mavacamten demonstrated in patients with symptomatic obstructive hypertrophic cardiomyopathy
Bookmark1. Mavacamten demonstrated substantial enhancement in alleviating valsalva left...
Read More
ESC: Mavacamten Cuts Need for Septal Reduction Tx with Hypertrophic Cardiomyopathy
TUESDAY, Aug. 29, 2023 (HealthDay News) — In patients with symptomatic obstructive...
Read More
Association between left atrial myopathy and sarcomere mutation in patients with hypertrophic cardiomyopathy: insights into left atrial strain by MRI feature tracking.
Left atrial (LA) myopathy, characterized by LA enlargement and mechanical dysfunction, is...
Read MoreAdvertisement
Saliency maps provide insights into artificial intelligence-based electrocardiography models for detecting hypertrophic cardiomyopathy.
A 12‑lead electrocardiography (ECG)-based convolutional neural network (CNN) model can detect hypertrophic cardiomyopathy (HCM). However, since these models do not rely on discrete measurements as inputs, it is not apparent what...
Read MoreHypertrophic Cardiomyopathy Complicated by Post-COVID-19 Myopericarditis in Patient with -Related Distal Myopathy.
A 60-year-old male with hypertrophic cardiomyopathy, conduction disorders, post-COVID-19 myopericarditis and heart failure was admitted to the hospital’s cardiology department. Blood tests revealed an increase in CPK...
Read More
Application of non-invasive bioreactance to assess hemodynamic function in patients with hypertrophic cardiomyopathy.
Non-invasive technologies have become popular for the clinical evaluation of cardiac function. The...
Read More
Aficamten May Lower Symptom Burden in Non-Obstructive Hypertrophic Cardiomyopathy
The open-label, dose-finding REDWOOD-HCM Cohort 4 study demonstrated that patients with...
Read More
Vigorous Exercise Not Harmful With Hypertrophic Cardiomyopathy
WEDNESDAY, May 24, 2023 (HealthDay News) — Among individuals with hypertrophic...
Read MoreMachine learning modeling identifies hypertrophic cardiomyopathy subtypes with genetic signature.
Previous studies have revealed that patients with hypertrophic cardiomyopathy (HCM) exhibit differences in symptom severity and prognosis, indicating potential HCM subtypes among these patients. Here, 793 patients with HCM were...
Read More
Obstructive Hypertrophic Cardiomyopathy: Survival Following Septal Reduction in Older Patients
The following is a summary of “Survival After Septal Reduction in Patients >65 Years Old...
Read More
Obstructive Hypertrophic Cardiomyopathy: Assessment of Aficamten
The following is a summary of “Phase 2 Study of Aficamten in Patients With Obstructive...
Read More
Outcomes on Obstructive Hypertrophic Cardiomyopathy in Mitral Valve Leaflet Length
The following is the summary of “Is anterior mitral valve leaflet length important in outcome of...
Read More
Hypertrophic Cardiomyopathy-Related Mortality
Despite a declining death toll from hypertrophic cardiomyopathy (HCM) in the United States,...
Read More
Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy
For a study, researchers sought to report the clinical presentation and natural history of...
Read More